vs
Side-by-side financial comparison of PCB BANCORP (PCB) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
Vanda Pharmaceuticals Inc. is the larger business by last-quarter revenue ($57.2M vs $29.2M, roughly 2.0× PCB BANCORP). On growth, PCB BANCORP posted the faster year-over-year revenue change (11.3% vs 7.6%). PCB BANCORP produced more free cash flow last quarter ($24.4M vs $-29.5M). Over the past eight quarters, PCB BANCORP's revenue compounded faster (10.4% CAGR vs 9.8%).
PCB Bank is an American community bank that focuses on the Korean-American community based in California and offers commercial banking services. It has branches in 8 states and is the third largest Korean American Bank after Bank of Hope and Hanmi Bank.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
PCB vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $29.2M | $57.2M |
| Net Profit | — | $-141.2M |
| Gross Margin | — | — |
| Operating Margin | 45.0% | -70.5% |
| Net Margin | — | -246.8% |
| Revenue YoY | 11.3% | 7.6% |
| Net Profit YoY | — | -2774.3% |
| EPS (diluted) | $0.65 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $29.2M | $57.2M | ||
| Q3 25 | $30.4M | $56.3M | ||
| Q2 25 | $29.3M | $52.6M | ||
| Q1 25 | $26.9M | $50.0M | ||
| Q4 24 | $26.2M | $53.2M | ||
| Q3 24 | $25.3M | $47.7M | ||
| Q2 24 | $24.2M | $50.5M | ||
| Q1 24 | $23.9M | $47.5M |
| Q4 25 | — | $-141.2M | ||
| Q3 25 | $11.4M | $-22.6M | ||
| Q2 25 | $9.1M | $-27.2M | ||
| Q1 25 | $7.7M | $-29.5M | ||
| Q4 24 | — | $-4.9M | ||
| Q3 24 | $7.8M | $-5.3M | ||
| Q2 24 | $6.3M | $-4.5M | ||
| Q1 24 | $4.7M | $-4.1M |
| Q4 25 | 45.0% | -70.5% | ||
| Q3 25 | 52.3% | -55.6% | ||
| Q2 25 | 43.3% | -73.2% | ||
| Q1 25 | 40.2% | -82.0% | ||
| Q4 24 | 39.3% | -19.3% | ||
| Q3 24 | 42.2% | -23.1% | ||
| Q2 24 | 36.3% | -20.1% | ||
| Q1 24 | 27.2% | -19.5% |
| Q4 25 | — | -246.8% | ||
| Q3 25 | 37.5% | -40.1% | ||
| Q2 25 | 31.0% | -51.7% | ||
| Q1 25 | 28.8% | -58.9% | ||
| Q4 24 | — | -9.2% | ||
| Q3 24 | 30.8% | -11.2% | ||
| Q2 24 | 25.9% | -9.0% | ||
| Q1 24 | 19.6% | -8.7% |
| Q4 25 | $0.65 | $-2.40 | ||
| Q3 25 | $0.78 | $-0.38 | ||
| Q2 25 | $0.62 | $-0.46 | ||
| Q1 25 | $0.53 | $-0.50 | ||
| Q4 24 | $0.46 | $-0.09 | ||
| Q3 24 | $0.52 | $-0.09 | ||
| Q2 24 | $0.43 | $-0.08 | ||
| Q1 24 | $0.33 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $207.1M | $84.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $390.0M | $327.2M |
| Total Assets | $3.3B | $488.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $207.1M | $84.9M | ||
| Q3 25 | $369.5M | $70.0M | ||
| Q2 25 | $263.6M | $81.0M | ||
| Q1 25 | $214.3M | $111.8M | ||
| Q4 24 | $198.8M | $102.3M | ||
| Q3 24 | $193.1M | $100.5M | ||
| Q2 24 | $177.6M | $103.0M | ||
| Q1 24 | $239.8M | $125.2M |
| Q4 25 | $390.0M | $327.2M | ||
| Q3 25 | $384.5M | $466.0M | ||
| Q2 25 | $376.5M | $486.3M | ||
| Q1 25 | $370.9M | $511.4M | ||
| Q4 24 | $363.8M | $538.5M | ||
| Q3 24 | $362.3M | $541.2M | ||
| Q2 24 | $353.5M | $542.5M | ||
| Q1 24 | $350.0M | $544.0M |
| Q4 25 | $3.3B | $488.9M | ||
| Q3 25 | $3.4B | $601.1M | ||
| Q2 25 | $3.3B | $624.7M | ||
| Q1 25 | $3.2B | $631.9M | ||
| Q4 24 | $3.1B | $656.2M | ||
| Q3 24 | $2.9B | $645.1M | ||
| Q2 24 | $2.9B | $651.4M | ||
| Q1 24 | $2.9B | $652.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.6M | $-29.4M |
| Free Cash FlowOCF − Capex | $24.4M | $-29.5M |
| FCF MarginFCF / Revenue | 83.6% | -51.6% |
| Capex IntensityCapex / Revenue | 7.5% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $46.0M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.6M | $-29.4M | ||
| Q3 25 | $16.4M | $-31.6M | ||
| Q2 25 | $4.9M | $-15.3M | ||
| Q1 25 | $2.3M | $-33.1M | ||
| Q4 24 | $39.0M | $-1.8M | ||
| Q3 24 | $11.9M | $-14.6M | ||
| Q2 24 | $14.6M | $-6.9M | ||
| Q1 24 | $8.2M | $7.6M |
| Q4 25 | $24.4M | $-29.5M | ||
| Q3 25 | $16.2M | $-31.8M | ||
| Q2 25 | $3.8M | $-15.6M | ||
| Q1 25 | $1.6M | $-33.6M | ||
| Q4 24 | $34.9M | $-2.0M | ||
| Q3 24 | $11.9M | $-14.7M | ||
| Q2 24 | $12.8M | $-7.0M | ||
| Q1 24 | $6.0M | $7.6M |
| Q4 25 | 83.6% | -51.6% | ||
| Q3 25 | 53.2% | -56.5% | ||
| Q2 25 | 13.1% | -29.6% | ||
| Q1 25 | 6.0% | -67.1% | ||
| Q4 24 | 133.2% | -3.8% | ||
| Q3 24 | 46.8% | -30.9% | ||
| Q2 24 | 53.1% | -13.9% | ||
| Q1 24 | 25.2% | 15.9% |
| Q4 25 | 7.5% | 0.2% | ||
| Q3 25 | 0.8% | 0.3% | ||
| Q2 25 | 3.7% | 0.6% | ||
| Q1 25 | 2.8% | 0.9% | ||
| Q4 24 | 15.5% | 0.4% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 7.3% | 0.2% | ||
| Q1 24 | 9.3% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 0.54× | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 2.33× | — | ||
| Q1 24 | 1.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PCB
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
